MayTech Global Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-908
Closed -$65.3K 34
2022
Q4
$65.3K Buy
+908
New +$68.5K 0.02% 46
2022
Q3
Sell
-908
Closed -$70K 37
2022
Q2
$70K Sell
908
-8
-0.9% -$609 0.02% 53
2022
Q1
$67K Hold
916
0.02% 58
2021
Q4
$57K Hold
916
0.01% 65
2021
Q3
$54K Hold
916
0.01% 52
2021
Q2
$61K Sell
916
-365
-28% -$23.8K 0.01% 48
2021
Q1
$81K Sell
1,281
-8
-0.6% -$498 0.02% 40
2020
Q4
$80K Hold
1,289
0.02% 38
2020
Q3
$78K Hold
1,289
0.02% 38
2020
Q2
$76K Hold
1,289
0.02% 38
2020
Q1
$72K Hold
1,289
0.03% 35
2019
Q4
$83K Buy
+1,289
New +$73.8K 0.04% 34

Other funds holding BMY

MayTech Global Investments's BMY Position: Q1 2023 in Review

MayTech Global Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 908 shares — an estimated $65.3K sold.

MayTech Global Investments first reported a position in BMY in Q4 2019 and held it in 12 quarters. The position peaked at $83K in Q4 2019. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

  • MayTech Global Investments reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
  • MayTech Global Investments sold 908 Bristol-Myers Squibb shares in Q1 2023, an estimated $65.3K.
  • MayTech Global Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 12 quarters.
  • MayTech Global Investments's Bristol-Myers Squibb position peaked at $83K in Q4 2019.
  • 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.